Clinical Trials on Logopenic Progressive Aphasia in Japan
Total 33 results
-
Santen Pharmaceutical Co., Ltd.Completed
-
Alcon ResearchCompletedCorneal Astigmatism | AphakiaJapan
-
National Center of Neurology and Psychiatry, JapanCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveJapan
-
Daiichi Sankyo Co., Ltd.CompletedFibrodysplasia Ossificans ProgressivaJapan
-
TakedaActive, not recruitingProgressive Familial Intrahepatic Cholestasis (PFIC)Japan
-
Kobe UniversityRecruitingCoronary Artery Disease ProgressionJapan
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Kobe UniversityCompletedCoronary Artery Disease ProgressionJapan
-
Kyorin UniversityCompletedDisease Progression | Autosomal Dominant Polycystic Kidney DiseaseJapan
-
Shinshu UniversityRecruitingOsteoarthritis of Multiple Joints | Progression of Rheumatoid ArthritisJapan
-
AbbVieTerminatedProgressive Supranuclear Palsy (PSP)United States, Australia, Canada, Italy, Japan
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple Sclerosis (SPMS)Japan
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingMetastatic Non-Small Cell Lung CancerRussian Federation, Australia, United States, Argentina, Canada, Colombia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Portugal, Puerto Rico, Spain, United Kingdom
-
Clementia Pharmaceuticals Inc.IpsenRecruitingFibrodysplasia Ossificans ProgressivaUnited States, Korea, Republic of, Belgium, China, Sweden, France, Japan, Argentina, Australia, Brazil, Canada, Italy, Spain, United Kingdom, Mexico, Colombia, Netherlands, Germany, Portugal
-
Novartis PharmaceuticalsActive, not recruitingRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
University of JazanCompletedChronic Obstructive Pulmonary Disease ExacerbationSaudi Arabia
-
Clementia Pharmaceuticals Inc.CompletedFibrodysplasia Ossificans ProgressivaUnited States, Canada, France, Australia, Argentina, Brazil, Italy, Japan, Spain, Sweden, United Kingdom
-
AbbVieTerminatedProgressive Supranuclear PalsyUnited States, Australia, Canada, France, Germany, Italy, Japan, Spain
-
BiogenTerminatedSupranuclear Palsy, ProgressiveUnited States, France, Italy, Korea, Republic of, Russian Federation, Spain, United Kingdom, Austria, Canada, Germany, Japan, Australia, Greece
-
Regeneron PharmaceuticalsRecruitingFibrodysplasia Ossificans ProgressivaJapan, United States, Korea, Republic of, Spain, France, Australia, United Kingdom, China, Poland, Malaysia, Italy, Finland, Hong Kong, South Africa, Chile, Brazil, Netherlands, Colombia
-
SanofiRecruitingPrimary Progressive Multiple SclerosisSpain, Italy, Turkey, India, Israel, Bulgaria, Mexico, Greece, Portugal, United States, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Estonia, France, Georgia, Germany, Hungary, Japan and more
-
SanofiActive, not recruitingSecondary Progressive Multiple SclerosisUnited States, Argentina, Belgium, Canada, Czechia, France, Germany, Greece, India, Israel, Netherlands, Norway, Portugal, Turkey, United Kingdom, Japan, Austria, Bulgaria, China, Denmark, Finland, Italy, Lithuania, Poland, Romania, Russian... and more
-
Kliniken Beelitz GmbHHannover Medical School; University Hospital Muenster; Medical University Innsbruck and other collaboratorsRecruitingParkinson Disease | Multiple System Atrophy | Progressive Supranuclear PalsyGermany, Austria, Israel, Italy, Poland, Spain, Japan, Korea, Republic of
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple SclerosisChina, Germany, United States, Romania, Italy, Austria, Belgium, Czechia, Spain, Australia, Canada, France, Israel, Switzerland, Japan, Bulgaria, Netherlands, United Kingdom, Estonia, Latvia, Lithuania, Russian Federation, Turkey, Slo... and more
-
AbbVieTerminatedCancer | Breast CancerUnited States, Germany, Japan, Puerto Rico
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Brazil, Canada, China, Germany, India, Israel, Italy, Japan, Korea, Republic of, Mexico, Puerto Rico, Russian Federation, Saudi Arabia, Spain, Turkey, United Arab Emirates, United Kingdom
-
Kyorin UniversityJapan Clinical Oncology GroupRecruitingRecurrence | Glioblastoma | ProgressionJapan
-
Eli Lilly and CompanyTerminatedAlzheimer's DiseaseUnited States, Australia, Canada, Japan
-
Bristol-Myers SquibbRecruitingProgressive Pulmonary FibrosisChina, United States, Japan, Korea, Republic of, Taiwan, Hungary, Canada, Argentina, Australia, Austria, Belgium, Brazil, Chile, Colombia, Czechia, Denmark, Finland, France, Germany, Greece, India, Ireland, Italy, Mexico, Netherlands, Peru, Polan... and more
-
Astellas Pharma Global Development, Inc.Approved for marketingAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsUnited States, Canada, Japan
-
HUYABIO International, LLC.Bristol-Myers SquibbRecruitingUnresectable or Metastatic Melanoma | Progressive Brain MetastasisSpain, United States, Italy, Japan, Belgium, France, New Zealand, Brazil, Korea, Republic of, Australia, Germany, Singapore, Czechia, Austria, South Africa, United Kingdom, Puerto Rico
-
Philip Morris Products S.A.RecruitingSmoking | Tobacco Use | COPDUnited States, Bulgaria, Czechia, Germany, Japan, Romania, Slovakia, United Kingdom
-
AbbVieCompletedSmall Cell Lung CancerUnited States, Australia, Belarus, Belgium, Brazil, Bulgaria, Canada, China, Croatia, Czechia, Denmark, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Latvia, Mexico, Netherlands, Poland, Portugal, Romania, Russian... and more